- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Cardiovascular Disease
The Practical Cardiology™ Cardiovascular Disease clinical resource center hosts content related to a wide array of cardiovascular conditions. The leading cause of death in the United States, the term cardiovascular disease encompasses a multitude of conditions and this page serves as a hub for information to several of the most common conditions, including atherosclerotic cardiovascular disease, acute coronary syndromes, hypertension, and more.
Influenza Responsible for Nearly 300k Heart Disease Deaths Per Year Globally
November 19, 2022
An analysis of data from 2010-2019 collected from 10 countries suggests influenza activity is responsible for 299k ischemic heart disease deaths per year on a global level.
FDA Warns 7 Companies Over Illegal Claims of Cardiovascular Benefits from Supplements
November 18, 2022
Announced in a statement on November 17, the US FDA issued letters to 7 companies related to unsupported claims of supplements being able to cure, treat, mitigate or prevent cardiovascular disease or related conditions, such as atherosclerosis, stroke or heart failure, in violation of the Federal Food, Drug, and Cosmetic Act.
Subcutaneous ICD Could Reduce Lead-Related Complications By More than 90%
November 14, 2022
Data from the ATLAS trial indicate use of a subcutaneous ICD was associated with a 92% reduction in lead-related complications compared to TV-ICD without compromising the effectiveness of shocks, but investigators express caution over an increased incidence of inappropriate shocks with the S-ICD.
CDC-Led Report Suggests 5-10 Years of Progress Against Cardiovascular Disease Erased During COVID-19 Pandemic
October 31, 2022
An analysis of trends in cardiovascular disease-related mortality from the US CDC WONDER database provides new insight into the apparent increases in mortality from cardiovascular disease observed during 2020 relative to the decreases in rate seen from 2010-2019.
Cardiology Month in Review: October 2022
October 29, 2022
The October 2022 cardiology month in review features the top content from HFSA 2022, new data related to antithrombotic therapy in atrial fibrillation, and shining a spotlight on the AHA’s scientific statement on patient-reported outcomes in peripheral artery disease.
Understanding Aficamten and the SEQUOIA-HCM Design, with Martin Maron, MD
October 05, 2022
Martin Maron, MD, sits down to discuss aficamten, the SEQUOIA-HCM trial, and the most pressing unmet needs in the management of hypertrophic cardiomyopathy.
Aficamten Could Improve Quality of Life, Symptom Burden in Hypertrophic Cardiomyopathy
October 02, 2022
Data presented at HFSA 2022 examining aficamten provides insight into the effects of the agent on LVOT-G, NYHA class, and KCCQ-OSS among patients with hypertrophic cardiomyopathy from the open-label extension trial.
Rates of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Falling in Recent Years
October 01, 2022
Martin Maron, MD, provides perspective on a recent study he led examining changes in rate of sudden cardiac death among patients with hypertrophic cardiomyopathy and reflects on the progress made within disease management.
Overview of Management for ATTR Amyloidosis with Cardiomyopathy, with Srinivas Murali, MD
September 29, 2022
Srinivas Murali, MD, of Allegheny Health Network, provides an overview of current management strategies for ATTR amyloidosis with cardiomyopathy as well as offering perspective on the recent APOLLO-B data.
Food Insecurity in the US Increasing, More Prevalent in those with Cardiovascular Disease
September 28, 2022
A University of Michigan-led analysis of NHANES data provides insight into the increases in prevalence of food insecurity among patients with cardiovascular disease in the US across racial and ethnic groups.